Genome British Columbia

Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented by partnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.

Tony Brooks

CFO and VP Entrepreneurship and Commercialization

Past deals in British Columbia

LightIntegra Technology Inc.

Venture Round in 2020
LightIntegra Technology Inc. is a medical diagnostics company based in Vancouver, Canada, founded in 2009. It specializes in in-vitro diagnostic tests aimed at improving platelet transfusion outcomes. Its primary product, ThromboLUX, provides both qualitative and quantitative analysis of microparticle content in platelet samples, which is essential for determining the suitability of platelet units for therapeutic or prophylactic use. The ThromboLUX test kit is complemented by a control kit and ThromboSight software, which assists healthcare professionals in analyzing test results. The company's innovation stems from research conducted in collaboration with Canadian Blood Services, led by Dr. Elisabeth Maurer, who utilized advancements in dynamic light scattering and laser technology to develop a rapid and effective diagnostic solution for assessing platelet quality and function.

BarrelWise

Seed Round in 2020
BarrelWise Technologies specializes in innovative solutions for the wine industry, focusing on improving production and analysis processes. Their flagship product, the FS1 System, revolutionizes routine free SO2 checks by allowing wineries to conduct these tests directly in the cellar, significantly reducing the time required from days to mere minutes while ensuring lab-level accuracy. Additionally, the technology facilitates various barrel management tasks, such as topping, sampling, sulfating, and chemical analysis, all without the need to open the barrel. This integrated approach enhances operational efficiency for wineries in regions like British Columbia, California, and Washington.

Acuva

Series B in 2019
Acuva Technologies Inc., founded in 2014 and headquartered in Vancouver, Canada, specializes in developing water treatment equipment utilizing ultraviolet light-emitting diode (UV-LED) technology. The company focuses on creating compact, modular, and scalable drinking water purification systems designed for low to moderate volumes of water. Acuva's systems effectively use short-wavelength radiation to inactivate microorganisms, including viruses and bacteria, by targeting and disrupting their DNA and nucleic acids. This process ensures the delivery of safe and hygienic drinking water, addressing the need for reliable water purification solutions in various applications.

Starling Minds

Seed Round in 2019
Starling Minds Inc. is a Vancouver-based company founded in 2013 that specializes in digital mental health therapy. It offers an online Cognitive Behavioral Therapy program designed to address stress, burnout, anxiety, and depression in workplace settings. The company provides comprehensive solutions for various sectors, including business, disability management, education, healthcare, insurance, and workers' compensation. By utilizing an artificial intelligence-powered platform, Starling Minds licenses its technology to insurance payers, healthcare providers, and employers in a business-to-business model. This approach aims to alleviate the chronic shortage of affordable mental health professionals by offering effective support for employees, facilitating their return to work, and promoting overall workplace productivity and mental well-being.

LightIntegra Technology Inc.

Series A in 2019
LightIntegra Technology Inc. is a medical diagnostics company based in Vancouver, Canada, founded in 2009. It specializes in in-vitro diagnostic tests aimed at improving platelet transfusion outcomes. Its primary product, ThromboLUX, provides both qualitative and quantitative analysis of microparticle content in platelet samples, which is essential for determining the suitability of platelet units for therapeutic or prophylactic use. The ThromboLUX test kit is complemented by a control kit and ThromboSight software, which assists healthcare professionals in analyzing test results. The company's innovation stems from research conducted in collaboration with Canadian Blood Services, led by Dr. Elisabeth Maurer, who utilized advancements in dynamic light scattering and laser technology to develop a rapid and effective diagnostic solution for assessing platelet quality and function.

Aspect Biosystems

Venture Round in 2018
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, focused on 3D bioprinting and tissue engineering. Founded in 2013, it develops bioprinted tissue therapeutics aimed at transforming disease treatment. The company utilizes proprietary microfluidic 3D bioprinting technology to create physiologically relevant living tissues, allowing for precise control over biomaterial composition and structure during fabrication. Aspect Biosystems offers contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical firms and academic institutions engaged in research related to respiratory diseases. Through partnerships with leading researchers and industry innovators, the company aims to address significant challenges in regenerative medicine and advance the understanding of human tissue creation for medical research and therapeutic discovery.

Microbiome Insights

Venture Round in 2017
Microbiome Insights Inc., based in Vancouver, Canada, specializes in microbiome analysis and testing services for researchers in academic and industrial sectors. Established in 2015, the company focuses on the diverse communities of microbial cells, including bacteria, viruses, and fungi that inhabit humans, animals, plants, and the environment. Microbiome Insights provides a comprehensive suite of services, including quantification of microbial populations, genetic potential analysis of microbial communities, and gene expression analysis. Their multidisciplinary team, comprising experts in ecology, microbiology, infectious diseases, and genetics, ensures researchers and clinicians can seamlessly incorporate microbiome analysis into studies across various fields, including human health, agriculture, and environmental science. The company is recognized for its commitment to delivering rapid, reliable, and cost-effective results.

CuePath Innovation

Seed Round in 2017
CuePath Innovation Inc. is a health technology company based in Vancouver, Canada, founded in 2015. The company specializes in developing a mobile application and smart disposable medication packaging aimed at helping caregivers monitor the medication intake of elderly patients and other vulnerable individuals. By facilitating remote tracking, CuePath's platform connects seniors with their caregivers and healthcare professionals, allowing families to ensure that their loved ones adhere to their medication regimens. This innovative approach not only promotes medication compliance but also supports the independence and health of seniors, thereby alleviating the stress associated with caregiving.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.